港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

497.950

+14.7953.06%

漲家數：18

跌家數：10

平家數：5

市盈率：- -

高：501.406

開：483.278

低：478.821

收：483.155

成交量：5,258.49萬

成交額：17.74億

市值：3,160.51億

流通市值：2,814.51億

資料載入中...

董事會主席吳以芳增持雲頂新耀(01952)2萬股每股作價約28.71港元

智通财经网

創新藥將迎數據催化窗口！OS、PFS、ORR還都分不清楚？速查指南來了！收藏備用

重磅大會在前，創新藥未有起色，什麼情況？華寶基金港股通創新藥ETF（520880）失守所有均線

歸創通橋(02190)9月11日斥資111.75萬港元回購5.5萬股

康寧傑瑞製藥-B(09966.HK)9月11日斥資約97.75萬港元回購12.3萬股

再鼎醫藥(09688)授出部分受限制股份單位

榮昌生物(09995.HK)9月11日斥資215.52萬元回購1.9萬股A股

麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂

昂利康創新藥引進項目告吹：授權合作折戟背後，主業承壓研發布局遇變數

一品紅痛風創新藥Ⅲ期臨床達到主要終點大中華區銷售峯值預計達19.5億元

康方生物(09926)出現大手賣出5.7萬股，成交價$90.5，涉資515.85萬

阿斯达克财经

啓明醫療－Ｂ(02500)股價上升6.41%，現價港幣$1.245

阿斯达克财经

同源康醫藥－Ｂ(02410)股價上升8.209%，現價港幣$2.9

阿斯达克财经

同源康醫藥-B(02410)：短期股價波動無礙長期邏輯，大股東增持疊加穩中向好基本面打開配置空間

智通财经网

基石藥業－Ｂ(02616)股價下跌8.059%，現價港幣$5.59

阿斯达克财经

德琪醫藥－Ｂ(06996)股價下跌8.406%，現價港幣$3.16

阿斯达克财经

亞盛醫藥(06855)股價下跌5.028%，現價港幣$30.98

阿斯达克财经

港股異動 | 同源康醫藥-B(02410)升逾9% 董事長增持彰顯長期發展信心創新EGFR-TKI 重磅獲批

啓明醫療(02500.HK)折讓近11%配股兼發可換股債券料籌5億人幣

阿斯达克财经

科濟藥業-B盤中漲近5% 公司香港業務取得重要進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BK1574/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":497.95004,"timestamp":1789358399683,"preClose":483.15506,"halted":0,"volume":52584873,"delay":0,"changeRate":0.030622,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午間休市","change":14.794983,"latestTime":"09-14 12:00:00","open":483.2777,"high":501.40622,"low":478.82104,"amount":1774164075,"amplitude":0.046745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789362000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":3.606253,"peRate":160.422718,"turnoverRate":0.002001,"increases":18,"decrements":10,"flats":4,"marketCap":316050765968,"floatMarketCap":281451472616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":501.40622,"amplitude":0.046745,"preClose":483.15506,"low":478.82104,"pbRate":"3.606253","latestPrice":497.95004,"volume":52584873,"delay":0,"open":483.2777,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":516.325,"twentyDayClose":505.128,"sixtyDayClose":444.911,"secType":"PLATE","market":"HK","turnoverRate":0.002001,"peRate":160.422718,"marketCap":316050765968,"floatMarketCap":281451472616,"timestamp":1789358399683,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":18,"down":10,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666524123","title":"董事會主席吳以芳增持雲頂新耀(01952)2萬股 每股作價約28.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524123","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125762,"startTime":"0","endTime":"0","summary":"9月10日，董事会主席吴以芳增持云顶新耀(01952)2万股，每股作价28.7065港元，总金额约为57.41万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260911/20260911192313_55668.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260911/20260911192313_55668.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","EWH","01952","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666798529","title":"創新藥將迎數據催化窗口！OS、PFS、ORR還都分不清楚？速查指南來了！收藏備用","url":"https://stock-news.laohu8.com/highlight/detail?id=2666798529","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666798529?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125720,"startTime":"0","endTime":"0","summary":"创新药重磅提示！就在周六，2026年WCLC将正式开幕，康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司将公布旗下核心产品临床数据。III期达到终点，意味着获批概率大幅提升，属于实质性大利好。临床试验中通常报告“中位OS”，即50%患者存活的时间。FDA加速批准程序允许基于替代终点批准药物，但上市后需完成确证性试验。FDA规定，提交后30天内若无异议，IND自动生效。以优效性为目标的头对头试验证据级别最高。权重数据截至2026.8.31。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrw8907408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","MEDX","ORR","IBBQ","159992","LNGR","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大會在前，創新藥未有起色，什麼情況？華寶基金港股通創新藥ETF（520880）失守所有均線","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529140?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线，重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图：港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整？低位埋伏创新药，关注两大投资工具：港股通创新药ETF华宝：紧密跟踪恒生港股通创新药精选指数，100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","MEDX","520880","FLHK","BK1574","159992","BK1161","06978","IBBQ","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525663","title":"歸創通橋(02190)9月11日斥資111.75萬港元回購5.5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525663","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525663?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年9月11日，该公司斥资111.75万港元回购5.5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1587","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525574","title":"康寧傑瑞製藥-B(09966.HK)9月11日斥資約97.75萬港元回購12.3萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525574?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:14","pubTimestamp":1789121672,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525377","title":"再鼎醫藥(09688)授出部分受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525377","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525377?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:12","pubTimestamp":1789121556,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)公布，公司于2026年9月8日(美国东部时间)根据2024年股权激励计划授出部分受限制股份单位，涉及15.6万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK1574","LU2488822045.USD","BK4531","BK1161","09688","ZLAB","BK1588","BK4585","BK4588","BK4526","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666406725","title":"榮昌生物(09995.HK)9月11日斥資215.52萬元回購1.9萬股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666406725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666406725?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:06","pubTimestamp":1789117581,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["82846","03130","09995","BK1583","BK1574","02827","83130","LU2328871848.SGD","LU1969619763.USD","BK1161","03188","02846","83188","BK1147","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HART","MYLD","MEDX","BK1100","AGNG","RSPH","BK1583","CALF","BK4588","BK1574","159883","MDEV","BK4585","KCE","02041","LNGR","GDOC","PTH","09996","XMMO","LGHT","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544925","title":"昂利康創新藥引進項目告吹：授權合作折戟背後，主業承壓研發布局遇變數","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544925","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544925?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"9 月 6 日，昂利康发布公告宣布终止与亚飞生物、亲合力的 IMD\u001e1005肿瘤抗体药物授权许可合作。02主业盈利出现下滑，创新转型面临双重考验创新药引进受挫的同时，昂利康主业经营已经显现压力。原料药业务是昂利康的基本盘，业绩下滑说明核心主业易受行业周期、市场供需波动冲击，自身抗周期能力有待加强。未来昂利康既要稳固原料药基本盘，也需要平衡好资金投入与管线风险，审慎推进授权引进类项目。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5384750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","002940","BK0239","IBBQ","BK1161","BK1574","159992","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544603","title":"一品紅痛風創新藥Ⅲ期臨床達到主要終點 大中華區銷售峯值預計達19.5億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544603","media":"新浪证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:34","pubTimestamp":1789112040,"startTime":"0","endTime":"0","summary":"近日，一品红自愿披露关于痛风创新药AR882治疗痛风伴高尿酸血症患者Ⅲ期临床研究达到主要终点的公告。商业化权益方面，AR882为一品红自主研发的1类创新药，在大中华区拥有完整的开发、生产与商业化权益，且一品红具备成熟的自有慢病药商业化团队，无需对外支付销售分成。结合0.70的临床成功概率，最终AR882大中华区痛风适应症管线的风险调整净现值约为5.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-11/doc-inirmvzz2155509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK0239","IBBQ","BK1161","BK1574","159992","300723","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854124","title":"康方生物(09926)出現大手賣出5.7萬股，成交價$90.5，涉資515.85萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854124","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:05","pubTimestamp":1789110300,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在下午03:05出现大手卖出，成交量为5.7万，成交价为港币$90.5，涉资515.85万。至目前为止，股价跌3.259%，今日最高价为$92.7，而最低价为$90.25，总成交量为881.253万股，总成交金额港币$8.027亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609115325/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609115325/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU1794554557.SGD","IE00B543WZ88.USD","LU0634319403.HKD","LU0348767384.USD","LU0348784397.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0348766576.USD","LU0561508036.HKD","LU2476274308.USD","09926","LU0348735423.USD","IE00BPRC5H50.USD","LU0417516571.SGD","BK1574","LU1720050803.USD","LU0348827113.USD","LU2778985437.USD","LU0348825331.USD","LU2399975544.HKD","LU0417516902.SGD","LU2476274720.SGD","LU0540923850.HKD","KURE","LU0348783233.USD","LU1961090484.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666492035","title":"啓明醫療－Ｂ(02500)股價上升6.41%，現價港幣$1.245","url":"https://stock-news.laohu8.com/highlight/detail?id=2666492035","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666492035?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:29","pubTimestamp":1789108140,"startTime":"0","endTime":"0","summary":"[上升股]启明医疗－Ｂ(02500) 股价在下午02:28比前收市价上升6.41%，现股价为港币$1.245。至目前为止，今日最高价为$1.35，而最低价为$1.17。总成交量为131.6万股，总成交金额为港币$165.107万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111665/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111665/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1100","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546476","title":"同源康醫藥－Ｂ(02410)股價上升8.209%，現價港幣$2.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546476","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 14:05","pubTimestamp":1789106700,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午02:04比前收市价上升8.209%，现股价为港币$2.9。至目前为止，今日最高价为$2.99，而最低价为$2.515。总成交量为613.95万股，总成交金额为港币$1.711千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111558/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111558/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","02410","159938","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666545362","title":"同源康醫藥-B(02410)：短期股價波動無礙長期邏輯，大股東增持疊加穩中向好基本面打開配置空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2666545362","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666545362?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:13","pubTimestamp":1789103634,"startTime":"0","endTime":"0","summary":"近期，在基本面稳中向好、核心品种顺利获批附条件上市、大股东大幅增持情况下，同源康股价却在外部因素与短期市场情绪影响下“砸出洼地”，而这也为长期价值投资者留出了潜在的布局机会。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260911/20260911131405_46437.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260911/20260911131405_46437.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02410","09939","BK1574","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666480795","title":"基石藥業－Ｂ(02616)股價下跌8.059%，現價港幣$5.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2666480795","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666480795?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:55","pubTimestamp":1789098900,"startTime":"0","endTime":"0","summary":"[下跌股]基石药业－Ｂ(02616) 股价在上午11:54比前收市价下跌8.059%，现股价为港币$5.59。至目前为止，今日最高价为$5.99，而最低价为$5.59。总成交量为1.111千万股，总成交金额为港币$6.363千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112417/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112417/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666485825","title":"德琪醫藥－Ｂ(06996)股價下跌8.406%，現價港幣$3.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2666485825","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666485825?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:14","pubTimestamp":1789096440,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药－Ｂ(06996) 股价在上午11:13比前收市价下跌8.406%，现股价为港币$3.16。至目前为止，今日最高价为$3.5，而最低价为$3.16。总成交量为61.25万股，总成交金额为港币$198.37万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112316/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112316/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06996","BK1583","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666548304","title":"亞盛醫藥(06855)股價下跌5.028%，現價港幣$30.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2666548304","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666548304?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:12","pubTimestamp":1789096320,"startTime":"0","endTime":"0","summary":"[下跌股]亚盛医药(06855) 股价在上午11:12比前收市价下跌5.028%，现股价为港币$30.98。至目前为止，今日最高价为$32.48，而最低价为$30.98。总成交量为147.737万股，总成交金额为港币$4.663千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112308/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609112308/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","06855","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510406","title":"港股異動 | 同源康醫藥-B(02410)升逾9% 董事長增持彰顯長期發展信心 創新EGFR-TKI 重磅獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510406","media":"智通财经","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510406?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 11:01","pubTimestamp":1789095677,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B今早拉升逾9%，截至发稿，涨9.7%，报2.94港元，成交额963.22万港元。消息面上，同源康医药昨晚公布，董事长、执行董事兼总裁吴豫生告知，于本月8至10日期间，于公开市场购入63.5万股H股，占已发行股本总额约0.17%，总代价约209万港元。公司表示，吴豫生已告知未来可能继续根据市场情况购买股份。此次进一步增持股份彰显对集团未来发展前景的信念及充分信心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1515","KCAI","VXUS","BK1574","BK4588","159938","BK1161","02410","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666101235","title":"啓明醫療(02500.HK)折讓近11%配股兼發可換股債券  料籌5億人幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2666101235","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666101235?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:50","pubTimestamp":1789095000,"startTime":"0","endTime":"0","summary":"启明医疗公布，于昨日交易时段后，与认购人杭州盈智勤(参)号股权投资合伙企业订立协议，将配发1.85亿股待认购股份及本金额不超过3.797亿港元的可转换债券。可转换债券初步转换价为每股转换股份1.1858港元，较前交易日收市价每股1.170港元折让2%。认购事项项下投资总额不超过5亿元人民币，公司拟将所得款项净额用于支付研发、临床及监管费用；补充一般企业营运资金；及偿还未偿还贷款。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201222151856754_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201222151856754_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543983/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543983/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1100","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510692","title":"科濟藥業-B盤中漲近5% 公司香港業務取得重要進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510692","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510692?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:42","pubTimestamp":1789094520,"startTime":"0","endTime":"0","summary":"模拟交易客户端科济药业-B盘中涨近5%。科济药业宣布，公司在香港地区的先进疗法产品相关业务取得重要进展，已获得开展相关药剂制品批发供应业务所需的许可资质。此次许可的取得，是科济药业推进恺力美国际化布局的重要里程碑，为公司进一步探索恺力美在香港地区的患者可及路径及相关业务开展奠定了基础，也为公司持续拓展海外市场积累了重要经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-11/doc-inirmmnc5377838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1587","BK1574","02171","BK1585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":2,"totalSize":344,"code":"91000000","status":"200"}]}}